Bifogade filer
PDF
Beskrivning
| Land | Norge |
|---|---|
| Lista | Euronext Growth Oslo |
| Sektor | Informationsteknik |
| Industri | Programvara |
With reference to the share buyback program announced 5 June 2023, Nordhealth AS ("the Company") has reached the buyback program's maxiumum consideration of NOK 4 million as of 30 June. Under the share buyback program the Company purchased 154,013 of its own shares in the period 5 June 2023 to 30 June 2023 at an average price of NOK 25.9717 per share for a total consideration of NOK 3,999,975.21.
From 23 June 2023 until 30 June 2023, Nordhealth purchased a total of 35,800 own shares at an average price of NOK 27.0956 per share.
Aggregated overview of transactions per day:
Date Aggregate daily Weighted Total
volume (# of average price transaction
shares) (NOK) value (NOK)
23/06/2023 12,578 28.0549 352,874.53
26/06/2023 4,972 27.1079 134,780.48
27/06/2023 3,470 27.3050 94,748.35
28/06/2023 6,193 26.0840 161,538.21
29/06/2023 6,605 26.4164 174,480.32
30/06/2023 1,982 26.0345 51,600.38
Previously disclosed buy-backs 118,213 25.6313 3,029,952.94
under the programme (aggregate)
Total purchased under the 154,013 25.9717 3,999,975.21
programme
This information is published in accordance with the requirements in article 5 of the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
Appendix: A detailed overview of all transactions made under the buy-back programme that have been carried out during the above-mentioned time period is attached to this report.
For further information, please contact:
Charles Macbain, CEO
charles.macbain@nordhealth.com
Mari Orttenvuori, CFO
mari.orttenvuori@nordhealth.com